错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia

  • Joost B. Koedijk,
  • Inge van der Werf,
  • Livius Penter,
  • Marijn A. Vermeulen,
  • Farnaz Barneh,
  • Alicia Perzolli,
  • Joyce I. Meesters-Ensing,
  • Dennis S. Metselaar,
  • Thanasis Margaritis,
  • Marta Fiocco,
  • Hester A. de Groot-Kruseman,
  • Rubina Moeniralam,
  • Kristina Bang Christensen,
  • Billie Porter,
  • Kathleen Pfaff,
  • Jacqueline S. Garcia,
  • Scott J. Rodig,
  • Catherine J. Wu,
  • Henrik Hasle,
  • Stefan Nierkens,
  • Mirjam E. Belderbos,
  • C. Michel Zwaan,
  • Olaf Heidenreich

摘要

Because of the low mutational burden and consequently, fewer potential neoantigens, children with acute myeloid leukemia (AML) are thought to have a T cell-depleted or ‘cold’ tumor microenvironment and may have a low likelihood of response to T cell-directed immunotherapies. Understanding the composition, phenotype, and spatial organization of T cells and other microenvironmental populations in the pediatric AML bone marrow (BM) is essential for informing future immunotherapeutic trials about targetable immune-evasion mechanisms specific to pediatric AML. Here, we conducted a multidimensional analysis of the tumor immune microenvironment in pediatric AML and non-leukemic controls. We demonstrated that nearly one-third of pediatric AML cases has an immune-infiltrated BM, which is characterized by a decreased ratio of M2- to M1-like macrophages. Furthermore, we detected the presence of large T cell networks, both with and without colocalizing B cells, in the BM and dissected the cellular composition of T- and B cell-rich aggregates using spatial transcriptomics. These analyses revealed that these aggregates are hotspots of CD8+ T cells, memory B cells, plasma cells and/or plasmablasts, and M1-like macrophages. Collectively, our study provides a multidimensional characterization of the BM immune microenvironment in pediatric AML and indicates starting points for further investigations into immunomodulatory mechanisms in this devastating disease.